文献詳細
特集 Female Urologyの蘊奥―積み重ねられた知恵と技術の活かし方
〈女性性機能〉
文献概要
▶ポイント
・閉経に伴うエストロゲンなどの性ホルモン低下により閉経関連泌尿生殖器症候群(GSM)が生じる.GSMは性器症状,性交関連症状,下部尿路症状を呈する.
・GSM治療の第一選択は潤滑剤,保湿剤である.
・薬物治療はエストロゲンの局所・全身投与である.特にエストロゲン製剤の腟内投与はリスクが少なく,積極的に試みてよい治療である.
・閉経に伴うエストロゲンなどの性ホルモン低下により閉経関連泌尿生殖器症候群(GSM)が生じる.GSMは性器症状,性交関連症状,下部尿路症状を呈する.
・GSM治療の第一選択は潤滑剤,保湿剤である.
・薬物治療はエストロゲンの局所・全身投与である.特にエストロゲン製剤の腟内投与はリスクが少なく,積極的に試みてよい治療である.
参考文献
1) Portman DJ, et al : Genitourinary Syndrome of Menopause : New Terminology for Vulvovaginal Atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. J Sex Med 11 : 2865-2872, 2014
2) Winneker RC, et al : Progress and Prospects in Treating Postmenopausal Vaginal Atrophy. Clin Pharmacol Ther 89 : 129-132, 2011
3) Management of Symptomatic Vulvovaginal Atrophy : 2013 Position Statement of The North American Menopause Society. Menopause 20 : 888-902, 2013
4) 巴ひかる, 他 : 外陰腟症状質問票 (Vulvovaginal Symptoms Questionnaire ; VSQ) の日本語版作成と言語学的妥当性の検討. 日泌会誌112 : 173-178, 2021
5) The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society. Menopause 27 : 976-992, 2020
6) 関口由紀, 他 : GSM (Genitourinary Syndrome of Menopause) の外陰所見と治療の実際. 日女性骨盤底医会誌17 : 24-29, 2021
7) Pitsouni E, et al : Efficacy of Vaginal Therapies Alternative to Vaginal Estrogens on Sexual Function and Orgasm of Menopausal Women : A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Eur J Obstet Gynecol Reprod Biol 229 : 45-56, 2018
8) Athanasiou S, et al : Microablative Fractional CO2 Laser for the Genitourinary Syndrome of Menopause : Up To 12-Month Results. Menopause 26 : 248-255, 2019
9) Biehl C, et al : A Systematic Review of the Efficacy and Safety of Vaginal Estrogen Products for the Treatment of Genitourinary Syndrome of Menopause. Menopause 26 : 431-453, 2019
10) Goldstein I : Recognizing and Treating Urogenital Atrophy in Postmenopausal Women. J Womens Health (Larchmt) 19 : 425-432, 2010
11) Davis SR, et al : Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab 104 : 4660-4666, 2019
12) Traish AM, et al : Role of Androgens in Female Genitourinary Tissue Structure and Function : Implications in the Genitourinary Syndrome of Menopause. Sex Med Rev 6 : 558-571, 2018
13) Fernandes T, et al : Efficacy of Vaginally Applied Estrogen, Testosterone, or Polyacrylic Acid on Vaginal Atrophy : A Randomized Controlled Trial. Menopause 23 : 792-798, 2016
14) Salinger SL : Proliferative Effect of Testosterone Propionate on Human Vaginal Epithelium. Acta Endocrinol (Copenh) 4 : 265-284, 1950
15) Labrie F, et al : Efficacy of Intravaginal Dehydroepiandrosterone (DHEA) on Moderate to Severe Dyspareunia and Vaginal Dryness, Symptoms of Vulvovaginal Atrophy, and of the Genitourinary Syndrome of Menopause. Menopause 25 : 1339-1353, 2018
16) Portman DJ, et al : Ospemifene, a Novel Selective Estrogen Receptor Modulator for Treating Dyspareunia Associated with Postmenopausal Vulvar and Vaginal Atrophy. Menopause 20 : 623-630, 2013
17) Schiavi MC, et al : Overactive Bladder Syndrome Treatment with Ospemifene in Menopausal Patients with Vulvovaginal Atrophy : Improvement of Sexuality? Gynecol Endocrinol 34 : 666-669, 2018
掲載誌情報